Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Teva Pharmaceutical Industries Ltd. (TEVA), the world?s largest generic-drug maker, is seeking to transform a compound once rejected by Sanofi into the first treatment to succeed insulin for Type 1 diabetes.
The therapy, DiaPep277, is made from a human protein that stops the immune system from destroying the pancreatic beta cells that secrete insulin, a hormone needed to convert sugar, starches and other food into energy. The drug also helps control sugar levels in the blood, a late-stage study showed last month.
http://www.bloomberg.com/news/2011-...diabetes-therapy-once-rejected-by-sanofi.html
The therapy, DiaPep277, is made from a human protein that stops the immune system from destroying the pancreatic beta cells that secrete insulin, a hormone needed to convert sugar, starches and other food into energy. The drug also helps control sugar levels in the blood, a late-stage study showed last month.
http://www.bloomberg.com/news/2011-...diabetes-therapy-once-rejected-by-sanofi.html